The Food and Drug Administration (FDA) approved indications for verapamil include angina (chronic stable, vasospastic or Prinzmetal variant), unstable angina (crescendo, preinfarction), hypertension as add-on therapy, paroxysmal supraventricular tachycardia (PSVT) prophylaxis, and supraventricular tachycardia (SVT). Verapamil also has numerous non-FDA-approved indications. This activity outlines the indications, mechanism of action, administration methods, significant adverse effects, contraindications, toxicity, and monitoring, of verapamil so providers can direct patient therapy where it is indicated as part of the interprofessional team.

**Objectives:**
- Describe the mechanism of action of verapamil.
- Summarize the approved and off-label indications for verapamil.
- Identify the potential adverse effects associated with therapy with verapamil.
- Review interprofessional team strategies for improving care coordination and communication to properly use typhoid verapamil to improve patient outcomes for indicated conditions.